...patients with familial hypercholesterolemia and atherosclerotic cardiovascular disease this year. In the small molecule group, Shifa Biomedical Corp....
...N.Y. Roche (SIX:ROG; OTCQX:RHHBY), Basel, Switzerland Sanofi (Euronext:SAN; NYSE:SNY), Paris, France Serometrix LLC, Pittsford, N.Y. Shifa Biomedical Corp....

...improve adherence over oral approaches to inhibiting PCSK9. Pfizer Inc. , Liphorus Pharmaceuticals Inc. , Shifa Biomedical Corp....
...Regeneron Pharmaceuticals Inc. (NASDAQ:REGN), Tarrytown, N.Y. Sanofi (Euronext:SAN; NYSE:SNY), Paris, France Serometrix LLC, Pittsford, N.Y. Shifa Biomedical Corp....

...now has nine academic and nine industry collaborators. He highlighted two industry collaborations: one with Shifa Biomedical Corp....
...Pink:MPSYF), Martinsried, Germany Moulder Center for Drug Discovery Research at Temple University , Philadelphia, Pa. Shifa Biomedical Corp....

...all require parenteral administration, and orally available inhibitors still lag far behind. Serometrix LLC and Shifa Biomedical Corp....
...Inc. (NYSE:PFE), New York, N.Y. Roche (SIX:ROG; OTCQX:RHHBY), Basel, Switzerland Serometrix LLC , Pittsford, N.Y. Shifa Biomedical Corp....

...said. Serometrix LLC is developing small molecules to disrupt PCSK9's binding to LDL receptors, while Shifa Biomedical Corp....
...Pharmaceuticals Inc. (NASDAQ:REGN), Tarrytown, N.Y. Sanofi (Euronext:SAN; NYSE:SNY), Paris, France Serometrix LLC , Pittsford, N.Y. Shifa Biomedical Corp....

...to partner prior to Ph II) Idera Pharmaceuticals Inc. (NASDAQ:IDRA) NA Gene-silencing oligonucleotide SC Preclin Shifa Biomedical Corp....